NS Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

Home » Analysis » Vaxess timeline: The US biotech firm racing to bring its Covid-19 vaccine patch to clinical trials » Therapeutic_Experience_Redefined_MIMIX

Vaxess timeline: The US biotech firm racing to bring its Covid-19 vaccine patch to clinical trials

NS Medical Devices is using cookies

Vaxess’ attempts to develop a Covid-19 vaccine patch centre around its smart MIMIX technology (Credit: Vaxess Technologies)

Related Article

Biggest players in the global wound care market

RECOMMENDED COMPANIES

MOST READ

GE HealthCare, Elekta expand collaboration to boost radiation therapy

Philips secures FDA 510(k) approval for its Zenition 30 mobile C-arm

Hyalex Orthopaedics initiates clinical trials for Hyalex Knee Cartilage System

Expanse ICE gets FDA 510(k) clearance for ICE Aspiration System

Ambu secures FDA nod for new version of aScope Duodeno 2 solution

Recommended Whitepaper